atrium innovations inc (ATB:Toronto)
Financial Statements for atrium innovations inc (ATB)
| Currency in Millions of US Dollars | As of: | Dec 31 2009 | Dec 31 2010 Restated | Dec 31 2011 | Dec 31 2012 | 4 Year Trend |
| Revenues | 319.7 | 356.6 | 414.7 | 437.5 | ![]() ![]() ![]() ![]() | |
| TOTAL REVENUES | 319.7 | 356.6 | 414.7 | 437.5 | ![]() ![]() ![]() ![]() | |
| Cost of Goods Sold | 140.4 | 153.6 | 189.7 | 213.4 | ![]() ![]() ![]() ![]() | |
| GROSS PROFIT | 179.3 | 203.0 | 224.9 | 224.0 | ![]() ![]() ![]() ![]() | |
| Selling General & Admin Expenses, Total | 98.4 | 123.9 | 139.4 | 144.0 | ![]() ![]() ![]() ![]() | |
| R&D Expenses | 2.3 | 2.0 | 2.6 | 2.5 | ![]() ![]() ![]() ![]() | |
| Depreciation & Amortization, Total | 4.2 | -- | -- | -- | ![]() ![]() ![]() ![]() | |
| OTHER OPERATING EXPENSES, TOTAL | 105.0 | 125.9 | 142.0 | 146.6 | ![]() ![]() ![]() ![]() | |
| OPERATING INCOME | 74.3 | 77.1 | 82.9 | 77.5 | ![]() ![]() ![]() ![]() | |
| Interest Expense | -6.7 | -5.9 | -10.8 | -12.2 | ![]() ![]() ![]() ![]() | |
| Interest and Investment Income | 0.3 | 0.5 | 0.6 | 0.4 | ![]() ![]() ![]() ![]() | |
| Other Non-Operating Expenses, Total | -1.0 | -1.1 | 0.9 | 1.5 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Other Non-Operating Income (Expenses) | -0.7 | -1.4 | 1.3 | 0.8 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() | |
| Merger & Restructuring Charges | -- | -3.4 | -0.4 | -5.6 | ![]() ![]() ![]() ![]() | |
| Impairment of Goodwill | -- | -- | -- | -16.0 | ![]() ![]() ![]() ![]() | |
| Other Unusual Items, Total | -- | -- | -- | -6.1 | ![]() ![]() ![]() ![]() | |
| EBT, INCLUDING UNUSUAL ITEMS | 66.9 | 67.1 | 73.3 | 39.4 | ![]() ![]() ![]() ![]() | |
| Income Tax Expense | 18.2 | 19.2 | 16.7 | 4.1 | ![]() ![]() ![]() ![]() | |
| Minority Interest in Earnings | -- | -- | -0.6 | -0.1 | ![]() ![]() ![]() ![]() | |
| Earnings from Continuing Operations | 48.7 | 47.9 | 56.6 | 35.2 | ![]() ![]() ![]() ![]() | |
| NET INCOME | 48.7 | 47.9 | 55.9 | 35.2 | ![]() ![]() ![]() ![]() | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | 48.7 | 47.9 | 55.9 | 35.2 | ![]() ![]() ![]() ![]() | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | 48.7 | 47.9 | 55.9 | 35.2 | ![]() ![]() ![]() ![]() | |
| Recently Viewed | |||
| ATB:CN | C$14.19 CAD | +0.035 | |
| Company | Last | Change |
| Entia Biosciences Inc | $0.50 USD | 0.00 |
| Glanbia PLC | €10.88 EUR | -0.215 |
| Nutraceutical International Corp | $19.38 USD | -0.03 |
| USANA Health Sciences Inc | $67.95 USD | -0.08 |
| Vitamin Shoppe Inc | $43.91 USD | -0.45 |
| View Industry Companies | ||
Industry Analysis
ATB
Industry Average
| Valuation | ATB | Industry Range |
| Price/Earnings | 13.1x |
|
| Price/Sales | 1.0x |
|
| Price/Book | 1.0x |
|
| Price/Cash Flow | 11.5x |
|
| TEV/Sales | 0.3x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01









